The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Salvage ablative radiation therapy for loco-regionally recurrent pancreatic ductal adenocarcinoma following surgical resection.
 
Victor Ng
No Relationships to Disclose
 
Melissa Zinovoy
No Relationships to Disclose
 
Carla Hajj
No Relationships to Disclose
 
Paul Bernard Romesser
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - EMD Serono
Research Funding - EMD Serono
Travel, Accommodations, Expenses - Elekta
 
Abraham Jing-Ching Wu
Stock and Other Ownership Interests - Simphotek
Consulting or Advisory Role - AstraZeneca; MORE Health
Research Funding - CivaTech Oncology
Travel, Accommodations, Expenses - Alpha Tau; CivaTech Oncology
 
John J Cuaron
No Relationships to Disclose
 
William R. Jarnagin
Consulting or Advisory Role - Fujifilm
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Adicet Bio (I); Agios (I); Alnylam (I); AstraZeneca (I); Autem Medical (I); Bayer (I); BeiGene (I); Berry Genomics (I); Celgene; Center for Emerging & Neglected Diseases (CEND); CytomX Therapeutics; Eisai (I); Exelixis (I); Flatiron Health (I); Genentech/Roche (I); Genoscience Pharma (I); Helio Health (I); Incyte (I); Ipsen (I); Legend Biotech (I); Loxo; Merck; MINA THERAPEUTICS (I); Nerviano Medical Sciences (I); QED Therapeutics (I); Rafael Pharmaceuticals; RedHill Biopharma (I); Silenseed; Sillajen (I); SOBI; Surface Oncology (I); TheraBionic (I); twoXAR; Vector Health (I); Yiviva (I)
Research Funding - Arcus Ventures (Inst); AstraZeneca/MedImmune (Inst); BioNTech (Inst); Celgene (Inst); Genentech (Inst); Roche (Inst); Silenseed (Inst)
 
Christopher H. Crane
Stock and Other Ownership Interests - Oncternal Therapeutics
Honoraria - Elekta
Consulting or Advisory Role - TriSalus Life Sciences
Research Funding - Elekta (Inst)
 
Marsha Reyngold
No Relationships to Disclose